Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine

Inflammation Research

Volumn 46, Issue 1, 1997, Pages 4-18

  Mannaioni, P F ^a   Di Bello, M G ^a   Masini, E ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Adhesion molecules; Growth factor; Histamine; Inflammation; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; CELL ADHESION MOLECULE; CELL SURFACE PROTEIN; DIPYRIDAMOLE; HISTAMINE; ILOPROST; LORATADINE; NAFTIDROFURYL; PADGEM PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRAPIDIL;

ALLERGIC VASCULITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; BLOOD VESSEL INJURY; CELL ACTIVATION; CELL COMMUNICATION; CELL GRANULE; CELL STRUCTURE; ENTERITIS; GLOMERULONEPHRITIS; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY CELL; MEDIATOR RELEASE; NONHUMAN; ONTOGENY; PROTEIN EXPRESSION; RESPIRATORY DISTRESS; REVIEW; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD PLATELETS; CELL ADHESION MOLECULES; HISTAMINE; HUMANS; INFLAMMATION; PLATELET-DERIVED GROWTH FACTOR; SELECTINS;

EID: 0031014094     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00000158     Document Type: Review

References (119)

1. Copley AL. Roles of platelets in physiological defence mechanism and pathological conditions. Folia Haematol (Leipzig) 1979; 106:732-64.
2. Page CP. Platelets as inflammatory cells. Immunopharmacology 1989;17:51-9.
3. Capron A, Auriault C, Cesbron JY, Pancré V, Tonnel AB, Tsicopoulos A, et al. Platelets in allergy. Prog Allergy Clin Immunol 1987;5:22-7.
4. Foreman JC. The platelets. In: Dale MM, Foreman JC, editors. Textbook of Immunopharmacology. Oxford: Blackwell, 1984:53-6.
5. Fodinger M, Frisch G, Winkler K, Emminger W, Mitterbauer G, Gadner H, et al. Origin of human mast cells: development from transplanted hematopoietic stem cells after allogeneic bone marrow transplantation. Blood 1994;84:2954-9.
6. Lagunoff T, Martin TW. Agents that release histamine from mast cells. Ann Rev Pharmacol Toxicol 1983;23:331-51.
7. Masini E, Fantozzi R, Blandina P, Brunelleschi S, Mannaioni PF. The riddle of cholinergic histamine release from mast cells. Prog Med Chem 1985;22:268-89.
8. Mannaioni PF, Masini E. The release of histamine by free radicals. Free Rad Biol Med 1988;5:177-97.
9. Williams RM, Bienenstock J, Stead RH. Mast cells: the neuroimmune connection. Chem Immunol 1995;61:208-35.
10. Mustard JF, Packham M. Factors influencing platelet function: adhesion, release and aggregation. Pharmacol Rev 1970;22:97-187.
11. Botting R, Vane JR. Vasoactive mediators derived from the endothelium. Arch Mal Coeur 1988;82:1-14.
12. Clawson CC, White JG. Platelet interaction with bacteria. Am J Pathol 1971;65:381-95.
13. Wasserman SI. The regulation of inflammatory mediator production by mast cell products. Am Rev Respir Dis 1987;135:546-8.
14. Mannaioni PF, Masini E, Pistelli A, Vane JR. Mast cells as a source of superoxide anions and nitric oxide-like factor: relevance to histamine release. Int J Tiss Reac 1991;13: 271-8.
15. Markus AJ, Silk ST, Safier LB, Ulman HL. Superoxide production and reducing activity in human platelets. J Clin Invest 1977;59:149-58.
16. Joseph M, Capron A, Ameisen JC, Capron M, Vorng H, Pancré V, et al. The receptor for IgE on blood platelets. Eur J Immunol 1986;16:306-12.
17. Sitter H, Lorenz W, Klotter J, Lill H. Model for causality assessment. In: Neugebauer EA, Holaday JW, editors. Handbook of Mediators in septic shock. Boca Raton: CRC Press, 1943:499-521.
18. Joseph M, Auriault C, Capron A, Vorng H, Viens P. A new function for platelets: IgE dependent killing of schistosomes. Nature 1983;303:810.
19. Mannaioni PF, Pistelli A, Gambassi F, DiBello MG, Raspanti S, Masini E. Definition of platelet derived histamine-releasing factor and histaminergic receptors modulating platelet aggregation. Int Arch Allergy Appl Immunol 1991;94:301-2.
20. Knauer KA, Lichtenstein LM, Adkinson NF, Fish JE. Platelet activation during antigen induced airway reactions in asthmatic subjects. New Engl J Med 1981;304:1404-7.
21. Capron A, Ameisen JC, Joseph M, Auriault C, Tonnel AB, Caen J. New functions for platelets and their pathological implications. Int Arch Allergy Appl Immunol 1985;77:107-14.
22. McIntire FC, Roth LW, Richards RK. The in vitro release of histamine from the blood cells of sensitized rabbits: relationship to blood coagulation mechanisms. Am J Physiol 1949;159:332-6.
23. Katz G. Histamine release from blood cells in anaphylaxis in vitro. Science 1940;91:221.
24. Selak MA. Neutrophil-platelet interactions in inflammation. Receptor 1994;4:3-7.
25. Taubman MB, Rollins BJ, Poon M, Marmur J, Green RS, Berk BC, et al. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res 1992;70:314-25.
26. Wissler RW. Update on the pathogenesis of atherosclerosis. Am J Med 1991;91:18-35.
27. Moore S, Friedman RJ, Singal DP, Gauldie J, Blajchman M, Roberts RS. Inhibition of injury induced thromboatherosclerotic lesions by anti-platelet serum in rabbits. Thromb Haemost 1976;35:70-81.
28. Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, et al. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. J Clin Invest 1977;60: 1191-201.
29. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986;46:155-69.
30. Heldin CH, Westermark B. Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Regul 1990;1:555-66.
31. Östman A, Thyberg J, Westermark B, Heldin CH. PDGF-AA and PDGF-BB biosynthesis: proprotein processing in the Golgi complex and lysosomal degradation of PDGF-BB retained intracellularly. J Cell Biol 1992;118:509-19.
32. Marmur JD, Poon M, Rossikhina M, Taubman MB. Induction of PDGF-responsive genes in vascular smooth muscle. Implications for the early response to vessel injury. Circulation 1992;86 (Suppl 6):53-60.
33. Mikhail N, Fukuda N, Tremblay HJ, Hamet P. Platelets, growth factors and vascular smooth-muscle cells in hypertension and diabetes. J Cardiovasc Pharmacol 1993;22:S64-74.
34. Soma Y, Dvonch V, Grotendorst GR. Platelet-derived growth factor AA homodimer is the predominant isoform in human platelets and acute human wound fluid. FASEB J 1992;6:2996-3001.
35. Kelly JL, Sánchez A, Brown GS, Chesterman CN, Sleigh MJ. Accumulation of PDGF B and cell-binding forms of PDGF A in extracellular matrix. J Cell Biol 1993;121:1153-63.
36. Soma Y, Takehara K, Ishibashi Y. Alteration of the chemotactic response of human skin fibroblasts to PDGF by growth factors. Exp Cell Res 1994;212:274-7.
37. 2-macroglobulin. J Biol Chem 1995;270:16236-42.
38. Vissinger H, Husted SE, Kristensen SD, Nielsen HK. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. Angiology 1993;44:633-8.
39. Kaplan D, Chao FC, Stiles CD. Platelet α-granules contain a growth factor for fibroblasts. Blood 1978;53:1043-52.
40. Hwang DL, Latus LJ, Lev-Ran A. Effects of platelet-contained growth factors (PDGF, EGF, IGF-I and TGFβ) on DNA synthesis in porcine aortic smooth muscle cells in culture. Exp Cell Res 1992;200:358-60.
41. Rollins BJ, Stier P, Ernst T, Wong GG. Human JE encodes a monocyte secretory protein. Mol Cell Biol 1989;9:4687-95.
42. Bach MK, Brashler JR, Stout BK, Johnson HG, Sanders ME. Platelet-derived growth factor can activate purified primate, phorbol myristate acetate-primed eosinophils. Int Arch Allergy Appl Immunol 1991;94:167-8.
43. Sumiyoshi A, Asada Y, Kisanuki A, Hayashi T. Arterial intimal thickening. Nippon-Rinsho 1992;50:307-10.
44. Beitz JC, Kim IS, Calabresi P, Frackelton AR. Human microvascular endothelial cells express receptors for platelet-derived growth factor. Proc Natl Acad Sci USA 1991;88:2021-5.
45. Vassbotn FS, Havnen OK, Heldin CH, Holmsen H. Negative feedback regulation of human platelets via automne activation of the platelet-derived growth factor α-receptor. J Biol Chem 1994;269:13874-9.
46. Kullmann A, Vaillant P, Muller V, Martinet Y, Martinet N. In vitro effects of pentoxifylline on smooth muscle cell migration and blood monocyte production of chemotactic activity for smooth muscle cells: potential therapeutic benefit in the adult respiratory distress syndrome. Am J Respir Cell Mol Biol 1993;8:83-8.
47. Couser WG. Pathogenesis of glomerulonephritis. Kidney Int 1993;42:S19-26.
48. Couser WG, Johnson RJ. Mechanisms of progressive renal disease in glomerulonephritis. Am J Kidney Dis 1994;23:193-8.
49. Nakajima M, Hewitson TD, Mathews DC, Kincaid-Smith P. Platelet-derived growth factor mesangial deposits in mesangial IgA glomerulonephritis. Nephrol Dial Transplant 1991;6:11-6.
50. Takehara K, Igarashi A, Ishibashi Y. Dipyridamole specifically decreases platelet-derived growth factor release from platelets. Thromb Res 1990;12:73-9.
51. Barradas MA, Jagroop IA, Mikhailidis DP. Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets. Clin Chim Acta 1994;230: 157-67.
52. Bonfardeci G, Cimminiello C, Cantini L, Arpaia G, Aloisio M, Pozzi F. Platelet and endothelial response with trapidil in patients with peripheral obliterative arteriopathy. Int Angiol 1994;13:339-42.
53. Grosser T, Bonish D, Zucker TP, Schror K. Iloprost-induced inhibition of proliferation of coronary artery smooth muscle cells is abolished by homologous desensitization. Agents Actions Suppl 1995;45:85-91.
54. Zucker TP, Grosser T, Morinelli T, Halushka PV, Sachinidis A, Vetter H, et al. Potentiation of PDGF-induced growth responses in coronary artery smooth muscle cells by thromboxane. Agents Actions 1995;45:53-8.
55. Yomogida S, Nagaoka I, Saito K, Yamashima T. Evaluation of the effects of defensins on neutrophil functions. Inflamm Res 1996;45:62-7.
56. Tedder TF, Steeber TA, Chen A, Engel P. The selectins: vascular adhesion molecules. FASEB J 1995;9:866-73.
57. Diacovo TG, deFougerolles AR, Bainton DF, Springer TA. A functional integrin ligand on the surface of platelets: intracellular adhesion molecule-2. J Clin Invest 1994;94:1243-51.
58. Berman ME, Muller WA. Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J Immunol 1995;154:299-307.
59. Bajorath J, Hollenbaugh D, King G, Harte W, Eustice DC, Darveau RP, et al. CD62/P-selectin binding sites for myeloid cells and sulfatides are overlapping. Biochemistry 1994;33:1332-9.
60. Berg EL, Fromm C, Melrose J, Tsurushita N. Antibodies cross-reactive with E- and P-selectin block both E- and P-selectin functions. Blood 1995;85:31-7.
61. Auchampach JA, Oliver MG, Anderson DC, Manning AM. Cloning, sequence, comparison and in vivo expression of the gene encoding rat P-selectin. Gene 1994;145:251-5.
62. Hsu-Lin SC, Berman CL, Furie BC, August D, Furie B. A platelet membrane protein expressed during platelet activation and secretion. J Biol Chem 1984;259:9121-5.
63. Moore KL, Stults NL, Diaz S, Smith DF, Cummings RD, Varki A, et al. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol 1992;118:445-56.
64. Ma L, Raycroft L, Asa D, Anderson DC, Geng JG. A sialoglycoprotein from human leukocytes functions as a ligand for P-selection. J Biol Chem 1994;269:27739-46.
65. Dore M, Simon SI, Hughes BJ, Entman ML, Smith CW. P-selectin and CD 18-mediated recruitment of canine neutrophils under conditions of shear stress. Vet Pathol 1995;32:258-68.
66. Nagata K, Tsuji T, Todoroki N, Katagiri Y, Tanoue K, Yamazaki H, et al. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J Immunol 1993;151:3627-73.
67. Elstad MR, La Pine TR, Cowley FS, McEver RP, McIntye TM, Prescott SM, et al. P-selectin regulates platelet-activating factor synthesis and phagocytosis by monocytes. J Immunol 1995;155:2109-22.
68. Bureau MF, Arreto CD, Lefort J, Vargaftig BB. Albumin exchange and inflammatory cell recruitment in lungs of antigen-challenged guinea-pigs: role of histamine. J Appl Physiol 1994;77:252-61.
69. Piguet PF, Vesin C, Thomas F. Bombesin down modulates pulmonary fibrosis elicited in mice by bleomycin. Exp Lung Res 1995;21:227-37.
70. Bailie MB, Pearson JM, Lappin PB, Killam AL, Roth RA. Platelets and α-naphthylisothiocyanate-induced liver injury. Toxicol Appl Pharmacol 1994;128:207-13.
71. Sarode R, Bhasin D, Marwaha N, Roy P, Singh K, Panigrahi D, et al. Hyperaggregation of platelets in intestinal tuberculosis: role of platelets in chronic inflammation. Am J Hematol 1995;48:52-4.
72. Collins CE, Cahill MR, Newland AC, Rampton DS. Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 1994;106:840-5.
73. Schaufelberger HD, Uhr MR, McGuckin C, Logan RPH, Misiewicz JJ, Gordon-Smith EC, et al. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. Eur J Clin Invest 1994;24:656-63.
74. Bull BS, Bull MH. Hypotesis: disseminated intravascular inflammation as the inflammatory counterpart to disseminated intravascular coagulation. Proc Natl Acad Sci USA 1994;91:8190-4.
75. Neugebauer E, Rixen D, Lorenz W. Histamine in septic/endotoxic shock. In: Neugebauer EA, Holaday JW, editors, handbook of Mediators in septic shock. Boca Raton: CRC Press, 1993:52-126.
76. Dale MM, Foreman JC. Histamine as a mediator of allergic and inflammatory reaction. In: Dale MM, Foreman JC. editors. Textbook of Immunopharmacology. Oxford: Blackwell, 1984:115-25.
77. Masini E, Mannaioni PF. Effect of histamine on smooth muscle. In: Szekeres L, Papp J, editors. Pharmacology of smooth muscle. Handbook of Experimental Pharmacology, vol 111. Berlin, Heidelberg: Springer-Verlag, 1994:193-225.
78. Majno G, Shea SM, Leventhal M. Endothelial contraction induced by histamine type mediator. An electron microscopic study. J Cell Biol 1969;42:647-67.
79. Wu NZ, Baldwin AL. Transient venular permeability increase and endothelial gap formation induced by histamine. Am J Physiol 1992;262:H1238-47.
80. Mayhan WG. Nitric oxide accounts for histamine-induced increases in macromolecular extravasation. Am J Physiol 1994;226:H2369-73.
81. Baldwin AL, Thurston G. Changes in endothelial actin cytoskeleton in venules with time after histamine treatment. Am J Physiol 1995;268:H1528-37.
82. Niimi N, Noso N, Yamamoto S. The effect of histamine on cultured endothelial cells. A study of the mechanism of increased vascular permeability Eur J Pharmacol 1992;221:325-31.
83. Geng JG, Bevilacqua MP, Moore KL, McIntyre TM, Prescott SM, Kim JM, et al. Rapid neutrophil adhesion to activated endothelium mediated by GMP-140. Nature 1990;343:757-60.
84. Lorant DE, Patel KD, McIntyre TM, McEver RP, Prescott SM, Zimmerman GA. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991;115:223-34.
85. Robinson-White A, Beaven MA. Presence of histamine and histamine-metabolizing enzyme in rat and guinea-pig microvascular endothelial cells. J Pharmacol Exp Ther 1982;223:440-5.
86. Krstic MK, Stepanovic RM, Vuckovic SM, Krstic SK. Evidence that endothelium-dependent relaxation to histamine in the rat common carotid artery is mediated by EDRF. Arch Int Physiol Biochem Biophys 1992;100:101-3.
87. 3 receptors in the pithed rat. Naunyn-Schmiedeberg's Arch Pharmacol 1993;347:55-60.
88. Yuan Y, Granger HJ, Zawieja DC, DeFily DV, Chilian WM. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am J Physiol 1993;264:H1734-9.
89. Masini E, Gambassi F, Di Bello MG, Mugnai L, Raspanti S, Mannaioni PF. Nitric oxide modulates cardiac and mast cell anaphylaxis. Agents Actions 1994;41:C89-90.
90. 2 receptor. Nature 1973;244:287-8.
91. 2-receptor mediated inhibition of histamine release from isolated rat mast cells. Agents Actions 1982;12:85-8.
92. 2-receptor agonists in the guinea pig isolated heart. Br J Pharmacol 1987;90:459-56.
93. Ching TL, van der Hee RM, Bhoelan NM, Blauw J, Menge WMPB, de Jong J, et al. Histamine as a marker for hydroxyl radicals. Med Inflamm 1995;4:339-43.
94. Fantozzi R, Brunelleschi S, Banchelli Soldaini G, Blandina P, Masini E, Raimondi L, et al. N-Formylmethionyl-leucylphenyl-alanine: Different releasing effects on human neutrophils and rat mast cells. Agents Actions 1983;13:218-21.
95. Baumgartner HR, Born GVR. Effects of 5-hydroxytryptamine on platelet aggregation. Nature 1968;218:137-41.
96. Code CF. The histamine like activity of white blood cells. J Physiol 1937;90:485-500.
97. Pletscher A, Da Prada M. The organelles storing 5-hydroxytryptamine in blood platelets. In: Biochemistry and Pharmacology of Platelets. Ciba Foundation Symposium, Vol 35. Amsterdam: Elsevier. Excerpta Medica, 1975:261-78.
98. Da Prada M, Pletscher A, Tranzer JP, Knuchel H. Subcellular localization of 5-hydroxytryptamine and histamine in blood platelets. Nature 1967;216:1315-7.
99. Fukami MH, Holmsen H, Ugurbil K. Histamine uptake in pig platelets and isolated dense granules. Biochem Pharmacol 1984;33:3869-74.
100. Brown MJ, Ind PWH, Jenner DA. Platelet histamine. New Engl J Med 1980;303:756.
101. Gill DS, Barradas MA, Fonseca VA, Gracey L, Dandona P. Increased histamine content in leukocytes and platelets of patients with peripheral vascular disease. Am J Clin Pathol 1988;89:622-6.
102. Saxena SP, Brandes LJ, Beker AB, Simons KJ, La Bella FS, Gerrard JM. Histamine is an intracellular messenger mediating platelet aggregation. Science 1989;243:1596-9.
103. Masini E, Di Bello MG, Raspanti S, Bani Sacchi T, Maggi E, Mannaioni PF. Platelet aggregation and histamine release by immunological stimuli. Immunopharmacology 1994;28:19-29.
104. May B, Bak IJ. Biochemische und morphlogische untersuchungen zur serotonin-speicherung heim carcinoid-syndrom. Naunyn Schmiedeberg's Arch Exp Pathol Pharmacol 1968;260:175.
105. Mannaioni PF, Di Bello MG, Raspanti S, Gambassi F, Mugnai L, Masini E. Platelet histamine: characterization of the proaggregatory effect of histamine in human platelets. Int Arch Allergy Immunol 1992;99:394-6.
106. 1-receptor dependent increase in platelet aggregation is mediated by intracellular calcium. Agents Actions 1992: C402-5.
107. Gill DS, Barradas MA, Mikhailidis DP, Dandona P. Histamine uptake by human platelets. Clin Chim Acta 1987;168:177-85.
108. Fleischer A. Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemother 1968;32:1-16.
109. Da Prada M, Tranzer JP, Pletscher A. Storage of 5-hydroxytryptamine in human blood platelets. Experientia 1972;28:1328-9.
110. Solatunturi E, Tuomisto J. Uptake of 5-hydroxytryptamine and histamine by intracellular particles of rabbit blood platelets. Ann Med Exp Fenn 1968;46:447-52.
111. Ugurbil K, Fukami MH, Holmsen H. Proton NMR studies of nucleotide and amine storage in the dense granules of pig platelets. Biochemistry 1984;23:416-28.
112. Mannaioni PF, Di Bello MG, Raspanti S, Romano V, Bani Sacchi T, Cappugi P, et al. Storage and release of histamine in human platelets. Inflamm Res 1995;44:S16-7.
113. Humphrey JH, Jaques R. The release of histamine and 5-hydroxytryplamine (serotonin) from platelets by antigen-antibody reaction (in vitro). J Physiol 1955;128:9-27.
114. Mannaioni PF, Di Bello MG, Raspanti S, Gambussi F, Mugnai L, Masini E. Histamine release by human platelets. Agents Actions 1993;38:C203-5.
115. Mannaioni PF, Palmerani B, Pistelli A, Gambassi F, Giannella E, Bani Sacchi T, et al. Histamine release by platelet aggregation. Agents Actions 1990;30:44-8.
116. Brandes EJ, La Bella FS, Glavin GB, Paraskevas F, Saxena SP, McNicol A, et al. Histamine as an intracellular messenger. Biochem Pharmacol 1990;40:1677-81.
117. Pistelli A, Di Bello MG, Raspanti S, Masini E, Mannaioni PF. New pharmacological profiles of loratadine: effect on platelet aggregation and histamine release from repository cells. Agents Actions 1993;38:C200-2.
118. 1-antihistaminics: predictive in vitro correlates. J Natl Cancer Inst 1994;86:770-5.
119. Herd CM, Page CP. Do platelets have a role as inflammatory cells? In: Joseph M, editor. Immunopharmacology of platelets. London: Academic Press, 1996:1-20.